Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii

References

• Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91–102. doi:10.1038/nrmicro.2017.14829249812
   PubMed Web of Science ®Google Scholar
• Greene C, Wu J, Rickard AH, Xi C. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces. Lett Appl Microbiol. 2016;63(4):233–239. doi:10.1111/lam.1262727479925
   PubMed Web of Science ®Google Scholar
• Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–633. doi:10.1038/nrmicro241520676145
   PubMed Web of Science ®Google Scholar
• Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276–301.28369412
   PubMed Web of Science ®Google Scholar
• Amin M, Navidifar T, Shooshtari FS, et al. Association between biofilm formation, structure, and the expression levels of genes related to biofilm formation and biofilm-specific resistance of Acinetobacter baumannii strains isolated from burn infection in Ahvaz, Iran. Infect Drug Resist. 2019;12:3867–3881. doi:10.2147/IDR.S22898131853190
   PubMed Web of Science ®Google Scholar
• Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012;80(1):228–233. doi:10.1128/IAI.05913-1122083703
   PubMed Web of Science ®Google Scholar
• Luo LM, Wu LJ, Xiao YL, et al. Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones. BMC Microbiol. 2015;15:62. doi:10.1186/s12866-015-0397-525888221
   PubMed Web of Science ®Google Scholar
• Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology (Reading, England). 2008;154(Pt 11):3398–3409. doi:10.1099/mic.0.2008/019471-0
   PubMed Web of Science ®Google Scholar
• Pakharukova N, Tuittila M, Paavilainen S, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci USA. 2018;115(21):5558–5563. doi:10.1073/pnas.180096111529735695
   PubMed Web of Science ®Google Scholar
• Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009;191(19):5953–5963. doi:10.1128/JB.00647-0919633088
   PubMed Web of Science ®Google Scholar
• Shenkutie AM, Yao MZ, Siu GK, Wong BKC, Leung PH. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii isolates. Antibiotics (Basel, Switzerland). 2020;9(11). doi:10.3390/antibiotics9110817
   Web of Science ®Google Scholar
• Niu C, Clemmer KM, Bonomo RA, Rather PN. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol. 2008;190(9):3386–3392. doi:10.1128/JB.01929-0718281398
   PubMed Web of Science ®Google Scholar
• Nie D, Hu Y, Chen Z, et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci. 2020;27(1):26. doi:10.1186/s12929-020-0617-731954394
   PubMed Web of Science ®Google Scholar
• Walsh BJC, Wang J, Edmonds KA, et al. The response of Acinetobacter baumannii to hydrogen sulfide reveals two independent persulfide-sensing systems and a connection to biofilm regulation. mBio. 2020;11(3). doi:10.1128/mBio.01254-20.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute; Wayne PA. Performance Standards for Antimicrobial Susceptibility Testing, 30th Edition. CLSI M100. CLSI; 2020.
   Google Scholar
• Ramirez MS, Bonomo RA, Tolmasky ME. Carbapenemases: transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules. 2020;10(5):720. doi:10.3390/biom10050720
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy S, Shah BP, Lee HH, Martinez LR. Microbicides alter the expression and function of RND-type efflux pump AdeABC in biofilm-associated cells of Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2016;60(1):57–63. doi:10.1128/AAC.01045-1526459900
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179. doi:10.1016/S0167-7012(00)00122-610699673
   PubMed Web of Science ®Google Scholar
• Pakkulnan R, Anutrakunchai C, Kanthawong S, Taweechaisupapong S, Chareonsudjai P, Chareonsudjai S. Extracellular DNA facilitates bacterial adhesion during Burkholderia pseudomallei biofilm formation. PLoS One. 2019;14(3):e0213288. doi:10.1371/journal.pone.021328830856240
   PubMed Web of Science ®Google Scholar
• Zhang B, Yu P, Wang Z, Alvarez PJJ. Hormetic promotion of biofilm growth by polyvalent bacteriophages at low concentrations. Environ Sci Technol. 2020;54(19):12358–12365. doi:10.1021/acs.est.0c0355832886494
   PubMed Web of Science ®Google Scholar
• Tang M, Wei X, Wan X, Ding Z, Ding Y, Liu J. The role and relationship with efflux pump of biofilm formation in Klebsiella pneumoniae. Microb Pathog. 2020;147:104244. doi:10.1016/j.micpath.2020.10424432437832
   PubMed Web of Science ®Google Scholar
• Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol. 2004;42(5):1915–1922. doi:10.1128/JCM.42.5.1915-1922.200415131149
   PubMed Web of Science ®Google Scholar
• Gao B, Li X, Yang F, et al. Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant enterobacteriaceae. Front Pharmacol. 2019;10:262. doi:10.3389/fphar.2019.0026230967778
   PubMed Web of Science ®Google Scholar
• Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter baumannii: genotype-phenotype correlation. Molecules (Basel, Switzerland). 2019;24(10). doi:10.3390/molecules24101849
   Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–622. doi:10.1373/clinchem.2008.11279719246619
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30(1):409–447. doi:10.1128/CMR.00058-1627974412
   PubMed Web of Science ®Google Scholar
• Wolcott R, Dowd S. The role of biofilms: are we hitting the right target? Plast Reconstr Surg. 2011;127(Suppl 1):28s–35s. doi:10.1097/PRS.0b013e3181fca24421200270
   PubMed Web of Science ®Google Scholar
• Ni W, Han Y, Zhao J, et al. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;47(2):107–116. doi:10.1016/j.ijantimicag.2015.11.01126742726
   PubMed Web of Science ®Google Scholar
• Kengkla K, Kongpakwattana K, Saokaew S, Apisarnthanarak A, Chaiyakunapruk N. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis. J Antimicrob Chemother. 2018;73(1):22–32. doi:10.1093/jac/dkx36829069421
   PubMed Web of Science ®Google Scholar
• Cai Y, Lee W, Kwa AL. Polymyxin B versus colistin: an update. Expert Rev Anti Infect Ther. 2015;13(12):1481–1497. doi:10.1586/14787210.2015.109393326488563
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Timsit JF. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. 2019;32(1):69–76. doi:10.1097/QCO.000000000000051830520737
   PubMed Web of Science ®Google Scholar
• Qi L, Li H, Zhang C, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016;7:483. doi:10.3389/fmicb.2016.0048327148178
   PubMed Web of Science ®Google Scholar
• Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273–278. doi:10.2217/fmb.09.519327114
   PubMed Web of Science ®Google Scholar
• Khoshnood S, Savari M, Abbasi Montazeri E, Farajzadeh Sheikh A. Survey on genetic diversity, biofilm formation, and detection of colistin resistance genes in clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2020;13:1547–1558. doi:10.2147/IDR.S25344032547124
   PubMed Web of Science ®Google Scholar
• Lin MF, Lin YY, Lan CY. Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation. PeerJ. 2020;8:e9020. doi:10.7717/peerj.902032523805
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, Martí S, Soto S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008;14(3):276–278. doi:10.1111/j.1469-0691.2007.01916.x18190568
   PubMed Web of Science ®Google Scholar
• Shi N, Gao Y, Yin D, et al. The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa. Microb Pathog. 2019;137:103765. doi:10.1016/j.micpath.2019.10376531586475
   PubMed Web of Science ®Google Scholar
• Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother. 1996;40(11):2517–2522. doi:10.1128/AAC.40.11.25178913456
   PubMed Web of Science ®Google Scholar
• Ciofu O, Rojo-Molinero E, Macià MD, Oliver A. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304–319. doi:10.1111/apm.1267328407419
   PubMed Web of Science ®Google Scholar
• Jensen P, Briales A, Brochmann RP, et al. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms. Pathog Dis. 2014;70(3):440–443. doi:10.1111/2049-632X.1212024376174
   PubMed Web of Science ®Google Scholar
• De Groote VN, Verstraeten N, Fauvart M, et al. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol Lett. 2009;297(1):73–79. doi:10.1111/j.1574-6968.2009.01657.x19508279
   PubMed Web of Science ®Google Scholar
• McQueary CN, Actis LA. Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J Microbiol (Seoul, Korea). 2011;49(2):243–250. doi:10.1007/s12275-011-0343-7
   Web of Science ®Google Scholar
• Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology (Reading, England). 2003;149(12):3473–3484. doi:10.1099/mic.0.26541-0
   PubMed Web of Science ®Google Scholar
• Selasi GN, Nicholas A, Jeon H, et al. Differences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant Acinetobacter baumannii sequence type 191. PLoS One. 2016;11(9):e0162576. doi:10.1371/journal.pone.016257627622249
   PubMed Web of Science ®Google Scholar
• Smani Y, Fàbrega A, Roca I, Sánchez-Encinales V, Vila J, Pachón J. Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(3):1806–1808. doi:10.1128/AAC.02101-1324379205
   PubMed Web of Science ®Google Scholar
• Sánchez-Encinales V, Álvarez-marín R, Pachón-Ibáñez ME, et al. Overproduction of outer membrane protein A by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase. J Infect Dis. 2017;215(6):966–974. doi:10.1093/infdis/jix01028453834
   PubMed Web of Science ®Google Scholar
• Martín-Peña R, Domínguez-Herrera J, Pachón J, McConnell MJ. Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR. J Antimicrob Chemother. 2013;68(7):1572–1575. doi:10.1093/jac/dkt05723435692
   PubMed Web of Science ®Google Scholar
• Mayer C, Muras A, Romero M, López M, Tomás M, Otero A. Multiple quorum quenching enzymes are active in the nosocomial pathogen Acinetobacter baumannii ATCC17978. Front Cell Infect Microbiol. 2018;8:310. doi:10.3389/fcimb.2018.0031030271754
   PubMed Web of Science ®Google Scholar
• Altınok Ö, Boral B, Ergin A, Eser ÖK. Existence of biofilm and biofilm-associated virulence genes in multi-drug resistant invasive Acinetobacter baumannii isolates. Mikrobiyol Bul. 2020;54(1):40–49. doi:10.5578/mb.2020432050877
   PubMed Web of Science ®Google Scholar
• Liu H, Wu YQ, Chen LP, et al. Biofilm-related genes: analyses in multi-antibiotic resistant Acinetobacter baumannii isolates from Mainland China. Medical Sci Monit. 2016;22:1801–1807. doi:10.12659/MSM.898959
   PubMed Web of Science ®Google Scholar